United States Federal Court of Appeals Rules in Favor of KORU Medical Systems
April 13 2020 - 4:15PM
Business Wire
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:
KRMD) (“KORU Medical” or the “Company”) today announced that on
April 9, 2020 The United States Court of Appeals for the Federal
Circuit (“the Federal Circuit Court”) affirmed an earlier decision
by the United States District Court for the Eastern District of
Texas (Case No. 2:15-CV-01167-JRG-RSP) that granted KORU Medical’s
motion for summary judgement of non-infringement against EMED
Technologies (“EMED”).
As previously reported, EMED filed the case on June 25, 2015
claiming patent infringement on one of its patents by the Company’s
needle sets and seeking unspecified monetary damages.
About KORU Medical Systems
KORU Medical Systems develops, manufactures and commercializes
innovative and easy-to-use specialty infusion solutions that
improve quality of life for patients around the world. The FREEDOM
Syringe Infusion System currently includes the FREEDOM60® and
FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™
and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are
used for infusions administered in the home and alternate care
settings. For more information, please visit
www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200413005454/en/
The Equity Group Inc. Devin Sullivan Senior Vice
President 212-836-9608 dsullivan@equityny.com
Kalle Ahl, CFA Vice President 212-836-9614 kahl@equityny.com
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Apr 2023 to Apr 2024